Quest Diagnostics Incorporated (BIT:1QDX)
Italy
· Delayed Price · Currency is EUR | Market Cap | 19.70B |
| Revenue (ttm) | 9.40B |
| Net Income (ttm) | 841.48M |
| Shares Out | n/a |
| EPS (ttm) | 7.45 |
| PE Ratio | 23.42 |
| Forward PE | 19.44 |
| Dividend | 2.16 (1.46%) |
| Ex-Dividend Date | Oct 2, 2025 |
| Volume | n/a |
| Average Volume | n/a |
| Open | 148.45 |
| Previous Close | 148.45 |
| Day's Range | 148.45 - 148.45 |
| 52-Week Range | 138.70 - 179.35 |
| Beta | n/a |
| RSI | 72.56 |
| Earnings Date | Feb 10, 2026 |
About Quest Diagnostics
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,... [Read more]
Financial Performance
In 2025, Quest Diagnostics's revenue was $11.04 billion, an increase of 11.78% compared to the previous year's $9.87 billion. Earnings were $988.00 million, an increase of 14.09%.
Financial numbers in USD Financial StatementsNews
Digi Power X Graduates to Cboe Canada
TORONTO--(BUSINESS WIRE)---- $DGX #Cboe--Digi Power X Inc. has graduated from the venture markets and is now listed under the symbol DGX on Cboe Canada,.
Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer
Veteran M&A and transformation leader from Danaher and Patheon joins the Quest Diagnostics executive team SECAUCUS, N.J., Feb. 26, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provide...
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference
SECAUCUS, N.J., Feb. 25, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President & Chief Financ...
Quest Diagnostics CEO on using blood testing for Alzheimer's diagnosis
Quest Diagnostics CEO Jim Davis says the company's Alzheimer's testing through blood work can help disagnons the disease a lot sooner and get patients into specialist earlier.
Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call Transcript
Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call Transcript
Quest Diagnostics forecasts 2026 profit, revenue above estimates on lab test demand
Quest Diagnostics on Tuesday forecast 2026 profit and revenue above Wall Street estimates after beating expectations for fourth-quarter results on strong demand for its diagnostic tests.
Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share
Fourth quarter revenues of $2.81 billion, up 7.1% from 2024 Fourth quarter reported diluted earnings per share ("EPS") of $2.18, up 11.8% from 2024; and adjusted diluted EPS of $2.42, up 8.5% from 202...
Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization
SECAUCUS, N.J., Feb. 10, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that the Company's Board of Directors h...
The Great AI Squeeze: High Costs Take Center Stage In Hyperscalers' Earnings Reports
With more than half of S&P 500® companies reporting thus far, EPS growth for Q4 2025 currently stands at 13%. This week, 1,662 companies are expected to report, including results from McDonald's, Cisc...
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease
New test as sensitive as next-generation sequencing, and provides five-day specimen stability to support nationwide testing SECAUCUS, N.J., Feb. 2, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), ...
Quest Diagnostics: A Continuing Bullish Case For A Leader Among Diagnostic Testing Brands
Quest Diagnostics gets reaffirmed as a buy for the 3rd time in a row. Key bullish drivers include organic growth, macro demand, strong profit margins among peers, and an investment-grade view from Fit...
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year
SECAUCUS, N.J., Jan. 21, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been named to the Fortune® magazine 2026...
Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect
Jennifer Erickson succeeds longtime CEO David Dexter following more than 26 years of service PHOENIX, Jan. 15, 2026 /PRNewswire/ -- Sonora Quest Laboratories, together with its parent company Laborato...
Quest Diagnostics Incorporated (DGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Quest Diagnostics Incorporated (DGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026
SECAUCUS, N.J., Jan. 8, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full year 2...
Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium
SECAUCUS, N.J., Jan. 6, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that data will be shared on circulating tumor DNA (ct...
Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan
Quest also now provides comprehensive Collaborative Lab Solutions (Co-Lab) hospital lab management services for all 21 Corewell Health hospitals SOUTHFIELD, Mich. and GRAND RAPIDS, Mich.
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference
SECAUCUS, N.J. , Dec. 19, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading national provider of diagnostic information services, announced that Jim Davis, Chairman, CEO and P...
Digi Power X Inc. (DGX:CA) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript
Digi Power X Inc. (DGX:CA) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript
Quest Diagnostics Incorporated (DGX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Quest Diagnostics Incorporated (DGX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States
MENLO PARK, Calif.--(BUSINESS WIRE)-- #MSCare--Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative d...
Quest Diagnostics Incorporated (DGX) Presents at 7th Annual Healthcare Symposium Transcript
Quest Diagnostics Incorporated ( DGX) 7th Annual Healthcare Symposium November 14, 2025 8:50 AM EST Company Participants Asia Chang Conference Call Participants Kevin Dreyer - GAMCO Investors, Inc. C...
Digi Power X Inc. (DGX:CA) Q3 2025 Earnings Call Transcript
Digi Power X Inc. ( DGX:CA) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Participants Michel Amar - Chairman & CEO Presentation Operator Good morning, and welcome to Digi Power X Inc.'...
Daily Dividend Report: ADP, Agree Realty, Group 1, DGX, Aflac
The board of directors of ADP approved a $0.16 increase in the quarterly cash dividend to an annual rate of $6.80 per share, Maria Black, ADP's President and Chief Executive Officer, announced today. ...
Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J. , Nov. 11, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividen...